Pharmaceutical group

Dexcel

8 medicines3 countries

A group of 5 companies with 8 medicines in 3 countries.

Its medicines

Group structure

5 companies in 2 countries

Israel2

United Kingdom1

Dexcel Pharma LimitedAuthorisation holder

Headquarters not stated2

Dexcel-Pharma LtdAuthorisation holder · 6 medicines · listed in Sweden, United States
Dexcel Pharma GmbhAuthorisation holder · 2 medicines · listed in Spain, Italy +2

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

8 medicines

Medicine	Substance	Country	Status	Authorised
DICLOFENAC SODIUM100mg · Tablet, extended release	Diclofenac	United States	Marketed	2000
ESOMEPRAZOLE MAGNESIUM20mg base · Tablet, orally disintegrating, delayed release	Esomeprazole	United States	Not marketed	2020
HEMADY20mg · Tablet	Dexamethasone	United States	Marketed	2019
OMEPRAZOLE20mg · Tablet, orally disintegrating, delayed release	Omeprazole	United States	Marketed	2017
OMEPRAZOLE MAGNESIUM20mg base · Capsule, delayed release	Omeprazole	United States	Marketed	2009
PERIOCHIP2.5mg · Tablet	Chlorhexidine	United States	Not marketed	1998
Verapamil HCl Dexcel 240 SR, tabletten met gereguleerde afgifte 240 mgTablet met gereguleerde afgifte	Verapamil	Netherlands	Authorised	2000
PERIOCHIP 2,5 MG INSERTO PERIODONTAL2,5 mg · Inserto periodontal	Chlorhexidine	Spain	Withdrawn	2020

Sources and licences

Country	Medicines	Current	Past	Companies
United States	6	6	0	Companies All medicines
Spain	1	0	1	Companies All medicines
Netherlands	1	1	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

All 11 sources

Medicines and Healthcare products Regulatory Agency, United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.

Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Läkemedelsverket, Sweden

Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Health Sciences Authority / data.gov.sg

Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence

Licence: Singapore Open Data Licence

Report an error or request removal Corrections from the company itself are welcome.

Dexcel

Group structure

Israel2

United Kingdom1

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Dexcel

Group structure

Israel2

United Kingdom1

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Work with Prognia

Other big groups

Group structure

🇮🇱Israel2

🇬🇧United Kingdom1

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Group structure

🇮🇱Israel2

🇬🇧United Kingdom1

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Work with Prognia

Israel2

United Kingdom1

Israel2

United Kingdom1